| 義守大學 |
2013-10 |
Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus
|
Yung-Chuan Lu;Chao-Ping Wang;Chia-Chang Hsu;Cheng-An Chiu;Teng-Hung Yu;Wei-Chin Hung;Li-Fen Lu;Fu-Mei Chung;I-Ting Tsai;Hsien-Chang Lin;Yau-Jiunn Lee |
| 義守大學 |
2018-10 |
Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction
|
Chao-Ping Wang;Teng-Hung Yu;Cheng-Ching Wu;Wei-Chin Hung;Chia-Chang Hsu;I-Ting Tsai;Wei-Hua Tang;Fu-Mei Chung;Jer-Yiing Houng;Yau-Jiunn Lee;Yung-Chuan Lu |
| 中國文化大學 |
2022-10 |
Circulating serum amyloid A levels but not SAA1 variants predict long-term outcomes of angiographically confirmed coronary artery disease
|
Wu, Semon |
| 國立臺灣大學 |
2002 |
Circulating Soluble Fas Ligand Correlates with Disease Activity in Graves ' Hyperthyroidism
|
王治元; 鍾文彬; 張天鈞; 蔡元奮; WANG, CHIH-YUAN; ZHONG, WEN-BIN; CHANG, TIEN-CHUN; TSAI, YUAN-FEEN |
| 臺大學術典藏 |
2018-09-10T04:05:53Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Wang, C.-Y. and Zhong, W.-B. and Chang, T.-C. and Tsai, Y.-F.; CHIH-YUAN WANG; TIEN-CHUN CHANG |
| 臺大學術典藏 |
2020-06-01T09:06:43Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Chih-Yuan Wang;Zhong W.-B.;Chang T.-C.;Tsai Y.-F.; CHIH-YUAN WANG; Zhong W.-B.; Chang T.-C.; Tsai Y.-F. |
| 臺大學術典藏 |
2020-06-03T07:24:05Z |
Circulating soluble fas ligand correlates with disease activity in Graves' hyperthyroidism
|
Tsai Y.-F.;TIEN-CHUN CHANG;Zhong W.-B.;Wang C.-Y.; Wang C.-Y.; Zhong W.-B.; TIEN-CHUN CHANG; Tsai Y.-F. |
| 臺北醫學大學 |
2002 |
Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
|
鍾文彬; Wang CY; Zhong WB; Chang TC; Tsai YF; ; |
| 國立臺灣大學 |
2002 |
Circulating soluble Fas ligand correlates with disease activity in Graves’ hyperthyroidism.
|
蔡元奮 |
| 國家衛生研究院 |
2019-05-15 |
Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
|
Hsu, SC;Chang, JH;Hsu, YP;Bai, KJ;Huang, SK;Hsu, CW |
| 國立成功大學 |
2022 |
Circulating SSEA-1+ stem cell-mediated tissue repair in allergic airway inflammation
|
Chiu, Chiu C.-J.;Liao, C.-C.;Hsu, Y.-H.;Chiang, B.-L. |
| 國立臺灣大學 |
2015 |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung, Chi-Sheng; Chou, Chia-Hung; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Chen, Ying-Hsien; Chang, Yuan-Shian; Tsai, Yao-Chou; Su, Ming-Jai; Ho, Yi-Lwun; Chen, Ming-Fong; Wu, Kwan-Dun; Lin, Yen-Hung; 林彥宏; 洪啟盛; 陳明豐; 吳允升; 吳寬墩; 陳盈憲; 蘇銘嘉; 何奕倫 |
| 臺大學術典藏 |
2020-09-28T07:04:44Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Chen M.-F.; Ho Y.-L.; Su M.-J.; Tsai Y.-C.; Chang Y.-S.; Chen Y.-H.; Wu X.-M.; Chang Y.-Y.; Hung C.-S.; Chou C.-H. |
| 臺大學術典藏 |
2020-12-01T07:10:07Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.;Chou C.-H.;Wu X.-M.;Chang Y.-Y.;Wu V.-C.;Chen Y.-H.;Chang Y.-S.;Tsai Y.-C.;Su M.-J.;Yi-Lwun Ho;Chen M.-F.;Wu K.-D.;Lin Y.-H.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; YI-LWUN HO; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-12-23T02:57:33Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Hung C.-S.;Chou C.-H.;Wu X.-M.;Chang Y.-Y.;Vin-Cent Wu;Chen Y.-H.;Chang Y.-S.;Tsai Y.-C.;Su M.-J.;Ho Y.-L.;Chen M.-F.;Wu K.-D.;Lin Y.-H.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F. |
| 臺大學術典藏 |
2020-12-18T05:20:51Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; YEN-HUNG LIN |
| 臺大學術典藏 |
2021-05-31T06:17:57Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; MING-JAI SU; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2020-12-28T09:31:21Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Lin Y.-H.; Wu K.-D.; Chen M.-F.; Ho Y.-L.; Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; YING-HSIEN CHEN; Chang Y.-S.; Tsai Y.-C.; Su M.-J. |
| 臺大學術典藏 |
2021-11-30T04:54:03Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction
|
Hung C.-S.; Chou C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Chen Y.-H.; Chang Y.-S.; Tsai Y.-C.; Su M.-J.; Ho Y.-L.; Chen M.-F.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2018-09-10T15:21:32Z |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
|
Lin, Yen-Hung;Wu, Kwan-Dun;Chen, Ming-Fong;Ho, Yi-Lwun;Su, Ming-Jai;Tsai, Yao-Chou;Chang, Yuan-Shian;Chen, Ying-Hsien;Wu, Vin-Cent;Chang, Yi-Yao;Wu, Xue-Ming;Chou, Chia-Hung;Hung, Chi-Sheng;何奕倫;蘇銘嘉;陳盈憲;吳寬墩;吳允升;陳明豐;洪啟盛;林彥宏;VIN-CENT WU;YEN-HUNG LIN;YI-LWUN HO; Hung, Chi-Sheng; VIN-CENT WU; YEN-HUNG LIN; Chou, Chia-Hung; YI-LWUN HO; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Chen, Ying-Hsien; Chang, Yuan-Shian; Tsai, Yao-Chou; Su, Ming-Jai; Ho, Yi-Lwun; Chen, Ming-Fong; Wu, Kwan-Dun; Lin, Yen-Hung; 林彥宏; 洪啟盛; 陳明豐; 吳允升; 吳寬墩; 陳盈憲; 蘇銘嘉; 何奕倫 |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:18Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B. |
| 臺大學術典藏 |
2021-03-18T08:54:08Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2022-02-07T07:48:57Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; SUNG-HSIN KUO; Huang C.-S. |
| 臺大學術典藏 |
2021-12-09T06:35:42Z |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
|
Lin P.-H.; Wang M.-Y.; Lo C.; LI-WEI TSAI; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S. |
